Literatur
Hoes JN, Jacobs JW, Boers M et al (2007) EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases. Ann Rheum Dis 66:1560–1567
Kirwan JR, Bijlsma JW, Boers M, Shea BJ (2007) Effects of glucocorticoids on radiological progression in rheumatoid arthritis. Cochrane Database Syst Rev:CD006356
Midtvedt K, Hjelmesaeth J, Hartmann A et al (2004) Insulin resistance after renal transplantation the effect of steroid dose reduction and withdrawal. J Am Soc Nephrol 15:3233–3239
Buttgereit F, Doering G, Schaeffler A et al (2008) Efficacy of modified-release versus standard prednisone to reduce duration of morning stiffness of the joints in rheumatoid arthritis (CAPRA-1) a double-blind, randomised controlled trial. Lancet 371:205–214
Da Silva JA, Jacobs JW, Kirwan JR et al (2006) Safety of low dose glucocorticoid treatment in rheumatoid arthritis published evidence and prospective trial data. Ann Rheum Dis 65:285–293
de Nijs RN, Jacobs JW, Algra A et al (2004) Prevention and treatment of glucocorticoid-induced osteoporosis with active vitamin D3 analogues a review with meta-analysis of randomized controlled trials including organ transplantation studies. Osteoporos Int 15:589–602
Hooper L, Brown TJ, Elliott R et al (2004) The effectiveness of five strategies for the prevention of gastrointestinal toxicity induced by non-steroidal anti-inflammatory drugs systematic review. BMJ 329:948
Deeks JJ, Smith LA, Bradley MD (2002) Efficacy, tolerability, and upper gastrointestinal safety of celecoxib for treatment of osteoarthritis and rheumatoid arthritis systematic review of randomised controlled trials. BMJ 325:619
Schlaghecke R, Kornely E, Santen RT, Ridderskamp P (1992) The effect of long-term glucocorticoid therapy on pituitary-adrenal responses to exogenous corticotropin-releasing hormone. N Engl J Med 326:226–230
Simon D, Fernando C, Czernichow P, Prieur AM (2002) Linear growth and final height in patients with systemic juvenile idiopathic arthritis treated with longterm glucocorticoids. J Rheumatol 29:1296–3000
Interessenkonflikt
Die korrespondierende Autorin gibt an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kolar, P., Buttgereit, F. Evidenzbasierte EULAR-Empfehlungen zum Management einer systemischen Glukokortikoid-Therapie bei rheumatischen Erkrankungen. Z. Rheumatol. 68, 349–352 (2009). https://doi.org/10.1007/s00393-008-0420-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00393-008-0420-4